5NG Profitability Analysis: Past Growth, Margins, Return on Capital, Free Cash Flow, and more - Healthway Medical Corporation Ltd - Alpha Spread

Healthway Medical Corporation Ltd
SGX:5NG

Watchlist Manager
Healthway Medical Corporation Ltd Logo
Healthway Medical Corporation Ltd
SGX:5NG
Watchlist
Price: 0.047 SGD Market Closed
Market Cap: 213.1m SGD
Have any thoughts about
Healthway Medical Corporation Ltd?
Write Note

Profitability Summary

Healthway Medical Corporation Ltd's profitability score is 52/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Healthway Medical Corporation Ltd

Revenue
160.8m SGD
Cost of Revenue
-26.9m SGD
Gross Profit
134m SGD
Operating Expenses
-122m SGD
Operating Income
12m SGD
Other Expenses
-3.3m SGD
Net Income
8.7m SGD

Margins Comparison
Healthway Medical Corporation Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SG
Healthway Medical Corporation Ltd
SGX:5NG
213.2m SGD
83%
7%
5%
US
Cigna Group
XMUN:CGN
89.8B EUR
12%
4%
2%
US
Cigna Corp
NYSE:CI
99.5B USD
12%
4%
2%
US
CVS Health Corp
NYSE:CVS
72.2B USD
15%
4%
2%
JP
GUPPY's Inc
TSE:5127
3.5T JPY
95%
32%
23%
DE
Fresenius Medical Care AG
XMUN:FME
21.2B EUR
25%
7%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.7B EUR
23%
6%
-5%
US
Laboratory Corporation of America Holdings
NYSE:LH
18.6B USD
28%
9%
4%
US
Quest Diagnostics Inc
NYSE:DGX
17B USD
33%
14%
9%
US
DaVita Inc
NYSE:DVA
14B USD
33%
15%
7%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.6B EUR
25%
7%
3%
Country SG
Market Cap 213.2m SGD
Gross Margin
83%
Operating Margin
7%
Net Margin
5%
Country US
Market Cap 89.8B EUR
Gross Margin
12%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 99.5B USD
Gross Margin
12%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 72.2B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country JP
Market Cap 3.5T JPY
Gross Margin
95%
Operating Margin
32%
Net Margin
23%
Country DE
Market Cap 21.2B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country DE
Market Cap 18.7B EUR
Gross Margin
23%
Operating Margin
6%
Net Margin
-5%
Country US
Market Cap 18.6B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country US
Market Cap 17B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 14B USD
Gross Margin
33%
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 10.6B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Healthway Medical Corporation Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SG
Healthway Medical Corporation Ltd
SGX:5NG
213.2m SGD
4%
3%
5%
5%
US
Cigna Group
XMUN:CGN
89.8B EUR
9%
2%
9%
7%
US
Cigna Corp
NYSE:CI
99.5B USD
9%
2%
9%
7%
US
CVS Health Corp
NYSE:CVS
72.2B USD
10%
3%
8%
5%
JP
GUPPY's Inc
TSE:5127
3.5T JPY
39%
26%
53%
101%
DE
Fresenius Medical Care AG
XMUN:FME
21.2B EUR
4%
2%
5%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.7B EUR
-6%
-2%
3%
1%
US
Laboratory Corporation of America Holdings
NYSE:LH
18.6B USD
5%
3%
8%
5%
US
Quest Diagnostics Inc
NYSE:DGX
17B USD
13%
6%
11%
8%
US
DaVita Inc
NYSE:DVA
14B USD
104%
5%
13%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.6B EUR
4%
2%
5%
3%
Country SG
Market Cap 213.2m SGD
ROE
4%
ROA
3%
ROCE
5%
ROIC
5%
Country US
Market Cap 89.8B EUR
ROE
9%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 99.5B USD
ROE
9%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 72.2B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
5%
Country JP
Market Cap 3.5T JPY
ROE
39%
ROA
26%
ROCE
53%
ROIC
101%
Country DE
Market Cap 21.2B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country DE
Market Cap 18.7B EUR
ROE
-6%
ROA
-2%
ROCE
3%
ROIC
1%
Country US
Market Cap 18.6B USD
ROE
5%
ROA
3%
ROCE
8%
ROIC
5%
Country US
Market Cap 17B USD
ROE
13%
ROA
6%
ROCE
11%
ROIC
8%
Country US
Market Cap 14B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
9%
Country DE
Market Cap 10.6B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top